Location: Menlo Park, CA
CIK: 0001631134 · Show all filings
Period: Q4 2018 (← Previous) (Next →)
Filing Date: Feb 22, 2019
Total Value: $803M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ASND | Ascendis Pharma A/S | 1,498,538 | $93.88M | 11.7% | $65.40 | — | ADR | 04351P101 |
| — | Amarin | 5,208,305 | $70.89M | 8.8% | $7.81 | — | ADR | 023111206 |
| — | ObsEva SA | 4,749,623 | $60.13M | 7.5% | $13.49 | — | COMM | H5861P103 |
| — | Principia Biopharma | 2,038,208 | $55.83M | 7.0% | $28.92 | — | COMM | 74257L108 |
| NTRA | Natera | 3,100,560 | $43.28M | 5.4% | $9.81 | +86.2% | COMM | 632307104 |
| — | Y-mAbs Therapeutics, Inc | 2,104,278 | $42.8M | 5.3% | $26.56 | — | COMM | 984241109 |
| — | Nucana Biomed Ltd | 2,400,000 | $34.8M | 4.3% | $19.00 | — | Ordinary Sh | GB00BYWYV |
| — | Nucana Biomed Ltd | 2,266,666 | $32.87M | 4.1% | $15.80 | — | ADR | 67022C106 |
| — | Merus N.V. | 1,961,039 | $27.45M | 3.4% | $18.53 | — | COMM | N5749R100 |
| CHRS | Coherus BioSciences | 2,868,221 | $25.96M | 3.2% | $10.94 | +5.8% | COMM | 19249H103 |
| — | Kiniksa Pharmaceuticals, Ltd | 922,700 | $25.92M | 3.2% | $17.35 | — | COMM CL A | G5269C101 |
| — | Audentes Therapeutics | 933,640 | $19.91M | 2.5% | $30.05 | — | COMM | 05070R104 |
| — | Spark Therapeutics | 481,270 | $18.84M | 2.3% | $66.59 | — | COMM | 84652J103 |
| SNY | Sanofi SA | 327,175 | $14.2M | 1.8% | $44.67 | — | ADR | 80105N105 |
| ACRS | Aclaris Therapeutics | 1,911,573 | $14.13M | 1.8% | $19.07 | -46.0% | COMM | 00461U105 |
| GILD | Gilead Sciences Inc | 213,331 | $13.34M | 1.7% | $53.01 | 0.0% | COMM | 375558103 |
| AZN | AstraZeneca PLC | 316,328 | $12.02M | 1.5% | $38.70 | — | ADR | 046353108 |
| INCY | Incyte Corp | 188,497 | $11.99M | 1.5% | $64.93 | 0.0% | COMM | 45337C102 |
| BMRN | Biomarin Pharmaceutical Inc | 140,542 | $11.97M | 1.5% | $95.13 | 0.0% | COMM | 09061G101 |
| — | TESARO Inc | 134,297 | $9.971M | 1.2% | $39.01 | — | COMM | 881569107 |
| HRTX | Heron Therapeutics Inc | 359,713 | $9.331M | 1.2% | $34.43 | -20.1% | COMM | 427746102 |
| — | Reata Pharmaceuticals Inc | 157,984 | $8.863M | 1.1% | $56.10 | — | COMM | 75615P103 |
| — | Iterum Therapeutics | 1,726,514 | $8.65M | 1.1% | $10.89 | — | COMM | G6333L101 |
| — | MorphoSys AG | 80,536 | $8.217M | 1.0% | $103.86 | — | COMM | D55040105 |
| — | Rigel Pharmaceuticals Inc | 3,382,174 | $7.778M | 1.0% | $3.17 | — | COMM | 766559603 |
| XNCR | Xencor Inc | 199,682 | $7.221M | 0.9% | $36.69 | 0.0% | COMM | 98401F105 |
| FOLD | Amicus Therapeutics Inc | 674,636 | $6.462M | 0.8% | $12.97 | -15.3% | COMM | 03152W109 |
| SVRA | Savara Inc | 754,372 | $5.711M | 0.7% | $11.26 | -20.1% | COMM | 805111101 |
| — | Deciphera Pharmaceuticals Inc | 265,475 | $5.572M | 0.7% | $20.99 | — | COMM | 24344T101 |
| — | Intercept Pharmaceuticals Inc | 54,472 | $5.491M | 0.7% | $100.80 | — | COMM | 45845P108 |
| SRPT | Sarepta Therapeutics Inc | 48,894 | $5.337M | 0.7% | $127.86 | -2.2% | COMM | 803607100 |
| — | Clovis Oncology Inc | 287,769 | $5.168M | 0.6% | $17.96 | — | COMM | 189464100 |
| — | Chiasma | 1,630,221 | $5.07M | 0.6% | $1.49 | — | COMM | 16706W102 |
| — | Entasis Therapeutics Holdings Inc. | 1,180,178 | $4.803M | 0.6% | $10.88 | — | COMM | 293614103 |
| NBIX | Neurocrine Biosciences Inc | 61,500 | $4.393M | 0.5% | $95.81 | 0.0% | COMM | 64125C109 |
| MGNX | MacroGenics Inc | 332,921 | $4.228M | 0.5% | $16.77 | 0.0% | COMM | 556099109 |
| — | Aimmune Therapeutics Inc | 175,775 | $4.205M | 0.5% | $27.66 | — | COMM | 00900T107 |
| — | Synlogic Inc. (fmrly Mirna) | 574,972 | $4.031M | 0.5% | $9.38 | — | COMM | 87166L100 |
| — | Dermira Inc | 542,224 | $3.899M | 0.5% | $10.38 | — | COMM | 24983L104 |
| PBYI | Puma Biotechnology Inc | 190,627 | $3.879M | 0.5% | $48.40 | -38.0% | COMM | 74587V107 |
| — | FibroGen Inc | 80,000 | $3.702M | 0.5% | $46.27 | — | COMM | 31572Q808 |
| — | Biohaven Pharmaceutical Holding Company Ltd | 97,445 | $3.604M | 0.4% | $37.55 | — | COMM | G11196105 |
| — | Orchard Therapeutics PLC | 222,618 | $3.502M | 0.4% | $15.73 | — | ADR | 68570P101 |
| — | Epizyme Inc | 563,655 | $3.472M | 0.4% | $8.45 | — | COMM | 29428V104 |
| — | Kadmon Holdings Inc | 1,651,172 | $3.435M | 0.4% | $3.01 | — | COMM | 48283N106 |
| — | Foamix Pharmaceuticals Ltd | 832,293 | $2.987M | 0.4% | $5.26 | — | COMM | M46135105 |
| FATE | Fate Therapeutics Inc | 229,813 | $2.948M | 0.4% | $12.98 | +7.4% | COMM | 31189P102 |
| — | Five Prime Therapeutics Inc | 315,344 | $2.933M | 0.4% | $9.30 | — | COMM | 33830X104 |
| — | GW Pharmaceuticals PLC | 30,000 | $2.922M | 0.4% | $97.40 | — | ADR | 36197T103 |
| — | Kala Pharmaceuticals Inc | 445,516 | $2.178M | 0.3% | $6.33 | — | COMM | 483119103 |
| — | ImmunoGen Inc | 447,075 | $2.146M | 0.3% | $4.80 | — | COMM | 45253H101 |
| RVLPQ | Osmotica Pharmaceuticals PLC | 253,089 | $1.961M | 0.2% | $8.00 | 0.0% | COMM | G6S41R101 |
| — | Otonomy Inc | 1,023,865 | $1.894M | 0.2% | $2.86 | — | COMM | 68906L105 |
| ANAB | AnaptysBio Inc | 25,020 | $1.595M | 0.2% | $82.97 | -10.4% | COMM | 032724106 |
| SNDX | Syndax Pharmaceuticals Inc | 350,110 | $1.558M | 0.2% | $6.42 | -14.6% | COMM | 87164F105 |
| — | Conatus Pharmaceuticals Inc | 638,197 | $1.104M | 0.1% | $4.96 | — | COMM | 20600T108 |
| — | Edge Therapeutics | 2,852,711 | $916K | 0.1% | $1.18 | — | COMM | 279870109 |
| PCRX | Pacira Pharmaceuticals Inc | 16,994 | $731K | 0.1% | $46.68 | 0.0% | COMM | 695127100 |
| APLS | Apellis Pharmaceuticals, Inc | 49,580 | $654K | 0.1% | $19.65 | -21.9% | COMM | 03753U106 |